Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBbva Ord Regulatory News (BVA)

Share Price Information for Bbva Ord (BVA)

Share Price is delayed by 15 minutes
Get Live Data
19.90    0.45 (2.31%)
Bid:
19.00
Ask:
19.90
Spread: 0.90 (4.737%)
Market Cap: €110.75b
BVA Live PriceLast checked at - London Stock Exchange

Intraday Bbva Ord Share Chart

BBVA offer modification

9 Jan 2025 17:48

RNS Number : 8202S
Banco Bilbao Vizcaya Argentaria SA
09 January 2025
 

Banco Bilbao Vizcaya Argentaria, S.A. ("BBVA"), in accordance with the provisions of the Securities Market legislation, hereby communicates, at the request of the Spanish Securities Market Commission (CNMV) and in accordance with the provisions of Article 234 of Law 6/2023, of March 17, on Securities Markets and Investment Services, the following:

 

INSIDE INFORMATION

 

In relation to the voluntary tender offer launched by BBVA for the entire share capital of Banco de Sabadell, S.A. ("Banco Sabadell" or the "Target Company") (the "Offer"), for which the prior announcement was published as inside information on May 9, 2024 and the request for authorisation was submitted to the CNMV on May 24, 2024 and gave leave to proceed on June 11, 2024, BBVA informs that it has decided to modify the Offer by reducing the minimum acceptance condition provided in the prior announcement, which implies a more favorable treatment for its recipients, in accordance with Article 31.1 of Royal Decree 1066/2007.

The aforementioned minimum acceptance condition, which initially required the acceptance of the Offer by at least 2,720,654,746 shares of the Target Company, representing 50.01 percent of its share capital, is now reduced so that it requires the Offer to be accepted for a number of shares that allows BBVA to acquire at least more than half of the effective voting rights of Banco Sabadell at the end of the Offer acceptance period (therefore excluding the treasury shares that the Target Company may hold at that time).

As of the date of this communication, the total share capital with voting rights amounts to 5,361,450,912 ordinary shares (5,361,450 effective voting rights), considering that Banco Sabadell's share capital is represented by a total of 5,440,221,447 ordinary shares (5,440,221 voting rights) and that it holds 78,770,535 treasury shares (as stated in Banco Sabadell's Universal Registration Document posted on the CNMV's website on May 23, 2024), whose voting rights are suspended in accordance with Article 148(a) of the Spanish Companies Act. Therefore, assuming that all such treasury shares remain as such at the end of the Offer acceptance period, the reduced minimum acceptance condition will be deemed fulfilled if the Offer is accepted for at least 2,680,726,000 shares of Banco Sabadell (2,680,726 voting rights), which would represent half plus one of Banco Sabadell's effective voting rights at that time.

The above notwithstanding, if Banco Sabadell's treasury shares vary by the end of the acceptance period, the condition will be deemed fulfilled if the Offer is accepted for the number of shares necessary to acquire more than 50 percent of the effective voting rights at that time, thus excluding the suspended voting rights corresponding to the treasury shares held by Banco Sabadell on that date.

In the event of a positive outcome of the Offer, BBVA will seek the redemption of Banco Sabadell's treasury shares at the end of the acceptance period at the first General Shareholders' Meeting of Banco Sabadell, reducing the share capital and locking up those shares in the meantime. 

The fulfillment of this reduced minimum acceptance condition, under the described terms, will make applicable the exception to the obligation to launch a mandatory tender offer in accordance with Article 8(f) of Royal Decree 1066/2007, to the extent that the Offer would have been accepted for shares representing, at least, 50 percent of the effective voting rights to which it was addressed.

BBVA will submit to the CNMV the documentation related to the improved terms of the Offer in accordance with Articles 17 and 20 of Royal Decree 1066/2007.

 

 

Madrid, January 9, 2025

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSSIFWUEISELF
Date   Source Headline
9th Dec 202510:30 amRNSPeriodic Report on the Buyback Program 2025/12/09
1st Dec 202510:25 amRNSPeriodic Report on the Buyback Program 2025/12/01
24th Nov 202510:42 amRNSPeriodic Report on the Buyback Program 2025/11/24
17th Nov 202510:44 amRNSPeriodic Report on the Buyback Program 2025/11/17
11th Nov 202511:13 amRNSPeriodic Report on the Buyback Program 11/11/2025
3rd Nov 20255:56 pmRNSIssuance of securities contingently convertible
30th Oct 20256:22 pmRNSPrudential capital requirements for 2026
30th Oct 20257:00 amRNS3Q25 Earnings Press Release
30th Oct 20257:00 amRNS3Q25 Earnings Presentation
30th Oct 20257:00 amRNS3Q25 Earnings Report
30th Oct 20257:00 amRNSExecution of a temporary own share buyback program
23rd Oct 202511:25 amRNS3Q25 Earnings Presentation Announcement
17th Oct 20257:00 amRNSPress release in relation to the VTO B.Sabadell
14th Oct 202510:53 amRNSInformation in relation to the VTO for B. Sabadell
7th Oct 20252:11 pmRNSFitch has upgraded BBVAs rating
3rd Oct 202512:19 pmRNSMoodys has upgraded BBVA’s rating
30th Sep 20257:00 amRNSDividend November 2025
25th Sep 202512:59 pmRNSSupplement exemption doc referred VTO B.Sabadell
22nd Sep 202512:28 pmRNSInformation in relation to the VTO for B.Sabadell
22nd Sep 20257:28 amRNSP.R. improvement offer to B.Sabadell shareholders
22nd Sep 20257:25 amRNSAmendment of the terms of the VTO for B.Sabadell
16th Sep 202512:37 pmRNSS&P has upgraded BBVAs rating
5th Sep 202512:57 pmRNSExemption doc in relation to the VTO to B.Sabadell
5th Sep 202510:51 amRNSOffer to Banco Sabadell Shareholders Presentation
5th Sep 202510:49 amRNSPress release offer to Banco Sabadell shareholders
5th Sep 202510:02 amRNSAnnouncement Offer to Banco Sabadell Presentation
5th Sep 20257:00 amRNSInformation regarding the VTO for B.Sabadell
29th Aug 20255:35 pmRNSInformation regarding the VTO for B.Sabadell
13th Aug 20255:58 pmRNSEarly redemption of Senior Non-Preferred
11th Aug 20256:13 pmRNSInformation regarding the VTO for Banco Sabadell
4th Aug 20257:00 amRNS2025 EBA Stress Test
31st Jul 20257:07 amRNS2Q25 Results Press Release
31st Jul 20257:06 amRNS2Q25 Quarterly Report
31st Jul 20257:02 amRNS2Q25 Earnings Presentation
24th Jul 20257:00 amRNS2Q25 Earnings Presentation Announcement
30th Jun 20255:32 pmRNSBBVA's decision on the takeover bid for Sabadell
25th Jun 20254:59 pmRNSIssuance of securities contingently convertible
24th Jun 20253:27 pmRNSAnnouncement on BBVA's takeover bid for Sabadell
12th Jun 20256:22 pmRNSBBVA Receives Updated MREL from Bank of Spain
27th May 20256:20 pmRNSInformation relation VTO launched BBVA-B.Sabadell
1st May 20257:00 amRNSAuthorisation of the CNMC
29th Apr 20254:51 pmRNS2024_Consolidated_Annual_Accounts&Management_Repor
29th Apr 20254:47 pmRNS2024_Individual_Annual_Accounts&Management_Report
29th Apr 20257:15 amRNS1Q25 Quarterly Report
29th Apr 20257:14 amRNSResults Press Release
29th Apr 20257:10 amRNS1Q25 Earnings Presentation
24th Apr 20257:00 amRNSRedemption of Mortgage Covered Bonds
24th Apr 20257:00 amRNSRedemption of Public Sector Covered Bonds
22nd Apr 202510:45 amRNS1Q 2025 earnings announcement
1st Apr 20255:26 pmRNSEarly redemption of Senior Preferred Notes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.